Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CODEPREX

CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

Standard Dose
EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CODEPREX is listed in Drugs@FDA under application 021369 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2004-06-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview CODEPREX is listed in Drugs@FDA under application 021369 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2004-06-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.